Loading…
CervoMed Inc. is projected to decline to $3.18 by 2027, a -11% move from its current price of $3.57. CRVO is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $3.31 | $3.57 | $3.85 | -0.01% |
| Jul 14 | $3.21 | $3.57 | $3.97 | -0.03% |
| Jul 15 | $3.13 | $3.57 | $4.07 | -0.04% |
| Jul 16 | $3.07 | $3.57 | $4.15 | -0.06% |
| Jul 17 | $3.01 | $3.57 | $4.22 | -0.07% |
| Jul 18 | $2.96 | $3.57 | $4.29 | -0.09% |
| Jul 19 | $2.92 | $3.57 | $4.36 | -0.10% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.92 | $3.57 | $4.36 | -0.10% |
| Week 2 | $2.69 | $3.56 | $4.73 | -0.21% |
| Week 3 | $2.52 | $3.56 | $5.03 | -0.31% |
| Week 4 | $2.38 | $3.56 | $5.30 | -0.42% |
| Week 5 | $2.27 | $3.55 | $5.55 | -0.52% |
| Week 6 | $2.17 | $3.55 | $5.79 | -0.63% |
| Week 7 | $2.09 | $3.54 | $6.01 | -0.73% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
CervoMed Inc. (CRVO) is a clinical-stage biotechnology company focused on the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the blood-brain barrier and inhibits the enzyme p38a.
Neflamapimod has the potential to reverse synaptic dysfunction, improve neuron health, and slow or prevent disease progression. Neflamapimod is currently in clinical development for the treatment of dementia with Lewy bodies, non-fluent variant primary progressive aphasia, amyotrophic lateral sclerosis, and amyotrophic lateral sclerosis. CervoMed Inc.
was founded in 2010 and is headquartered in Boston, Massachusetts.
CRVO is a healthcare stock trading at $3.74 per share and has a market capitalization of $34.63M. It ranks 4733 by market cap, placing it in a very small-cap segment of the market. The near-term price outlook blends neutral conditions with an eventual bullish shift, reflected in year-by-year targets that rise through the decade.
The forecast shows a path to higher prices starting around 2030, with 2030 averaging $4.59 and a max of $7.98, and 2040 averaging $7.14 with a max of $15.66, signaling meaningful upside potential.
A major floor 67.0% below — a decisive break under it would weaken the trend.
The nearest floor, 37.0% below — buyers have tended to step in here.
The nearest ceiling, 26.6% above — a clean break opens room to run.
A major ceiling 60.1% above — clearing it would confirm fresh momentum.
Key CRVO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CRVO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.54 | Buy | $3.56 | Buy |
| MA 10 | $3.47 | Buy | $3.51 | Buy |
| MA 20 | $3.45 | Buy | $3.44 | Buy |
| MA 50 | $3.37 | Buy | $3.51 | Buy |
| MA 100 | $3.76 | Sell | $4.05 | Sell |
| MA 200 | $5.62 | Sell | $5.17 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.34 | Neutral |
| Stoch RSI (14) | 40.40 | Neutral |
| CCI (20) | 19.10 | Neutral |
| Williams %R (14) | -54.37 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | -4.03 | Sell |
| Bollinger %B (20,2) | 0.55 | Neutral |
| Stochastic %K (14) | 45.63 | Neutral |
| TRIX (15) | 0.27 | Buy |
| Awesome (5,34) | 0.29 | Buy |
| Ultimate (7,14,28) | 56.78 | Neutral |
| Momentum (10) | 0.22 | Buy |
| Aroon Osc (25) | 16.00 | Buy |
| Hull MA (9) | 3.59 | Sell |
| ADX (14) | 14.03 | Neutral |
| ATR (14) | 0.24 | Info |
The 30-day technical picture is bullish, with RSI(14) at 60 and a constructed near-term bias supporting upside. The stock’s 50-day simple moving average stands at $3.37, while the 200-day simple moving average is at $5.65. Support is identified at $2.25 and resistance at $4.52, framing a 30-day trading range of $2.25 to $6.23.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.25 | $3.57 | $4.49 | 0% | Neutral | |
| $2.30 | $3.18 | $4.73 | -11% | Neutral | |
| $2.26 | $3.31 | $5.26 | -7% | Neutral | |
| $2.08 | $3.21 | $5.36 | -10% | Neutral | |
| $2.67 | $4.31 | $7.49 | +21% | Bullish | |
| $3.09 | $5.22 | $9.37 | +46% | Bullish | |
| $2.81 | $4.96 | $9.19 | +39% | Bullish | |
| $2.81 | $5.15 | $9.81 | +44% | Bullish | |
| $2.30 | $4.40 | $8.58 | +23% | Bullish | |
| $2.03 | $4.04 | $8.07 | +13% | Neutral | |
| $3.02 | $6.71 | $14.73 | +88% | Bullish | |
| $5.71 | $12.69 | $29.18 | +255% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.25 | $3.57 | $4.25 | +0.00% |
| August 2026 | $2.78 | $3.37 | $4.25 | -5.68% |
| September 2026 | $2.87 | $3.52 | $4.54 | +4.59% |
| October 2026 | $2.85 | $3.54 | $4.64 | +0.57% |
| November 2026 | $2.64 | $3.32 | $4.41 | -6.32% |
| December 2026 | $2.63 | $3.33 | $4.49 | +0.52% |
Click any year to see its month-by-month CRVO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect CRVO to range from $2.25 to $4.49 through 2026. The $3.57 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The CRVO price prediction for 2027 points to an average of $3.18 (low $2.30, high $4.73) — a potential decline of -11% on today's $3.57. Price action looks broadly range-bound.
In 2028, CRVO is projected to trade between $2.26 and $5.26, averaging $3.31 — a potential decline of -7% from today's $3.57. That is up +4% on the projected 2027 average. A consolidation phase looks the most probable path here.
CervoMed Inc.'s 2029 outlook centres on $3.21, within a $2.08 to $5.36 range. That is -3% versus the projected 2028 average. That marks a -10% change versus current levels. Price action looks broadly range-bound.
By 2030, CRVO could reach as high as $7.49, with a base case around $4.31 and support toward $2.67 — roughly +21% from $3.57. Buyers look set to stay in control over this stretch.
Expect CRVO to range from $3.09 to $9.37 through 2031. The $5.22 average target implies a +46% move from current prices. That is up +21% on the projected 2030 average. Momentum favours further upside here.
The CRVO price prediction for 2032 points to an average of $4.96 (low $2.81, high $9.19) — a potential gain of +39% on today's $3.57. Buyers look set to stay in control over this stretch.
In 2033, CRVO is projected to trade between $2.81 and $9.81, averaging $5.15 — a potential gain of +44% from today's $3.57. That is up +4% on the projected 2032 average. Momentum favours further upside here.
CervoMed Inc.'s 2034 outlook centres on $4.40, within a $2.30 to $8.58 range. That is -15% versus the projected 2033 average. That marks a +23% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, CRVO could reach as high as $8.07, with a base case around $4.04 and support toward $2.03 — roughly +13% from $3.57. Price action looks broadly range-bound.
Expect CRVO to range from $3.02 to $14.73 through 2040. The $6.71 average target implies a +88% move from current prices. That is up +66% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The CRVO price prediction for 2050 points to an average of $12.69 (low $5.71, high $29.18) — a potential gain of +255% on today's $3.57. Momentum favours further upside here.
Investing $1,000 in CRVO today (≈ 280.112045 CRVO) could be worth
$3,553.46
+$2,553.46 (+255%) by 2050 · US Dollar
Based on the average projected CRVO price of $12.69 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CRVOwould be worth at today's price.
$1,000 invested in CRVO on Jul 10, 2025 (≈ 138.696254 CRVO) would be worth
$495.15
-$504.85 (-50.5%) today · 0.50× · US Dollar
Based on a CRVO entry price of $7.21 vs. today's $3.57.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.55 | $1,005.63 | +0.6% |
| 1 month ago | $2.25 | $1,586.67 | +58.7% |
| 3 months ago | $3.83 | $932.11 | -6.8% |
| 6 months ago | $7.59 | $470.36 | -53.0% |
| 1 year ago | $7.21 | $495.15 | -50.5% |
| All time (5.0y) ago | $45.75 | $78.03 | -92.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CRVO forecast.
Our base-case forecast reaches $7.10 around 2050.
Implied market cap at $7.10: $65.74M
The multi-year forecast shows a shift to bullish sentiment from 2030 onward. In 2030 the average price is projected at $4.59 with a max of $7.98 and a min of $2.84, delivering an ROI of 22.9% and a bullish outlook. The trajectory through 2031–2034 remains bullish, with 2031 (avg $5.53; max $9.93; ROI 47.8%), 2032 (avg $5.28; max $9.79; ROI 41.3%), 2033 (avg $5.45; max $10.38; ROI 45.8%), and 2034 (avg $4.65; max $9.09; ROI 24.4%).
In 2035 the sentiment shifts to neutral. The forecast then accelerates into 2040 with an average of $7.14 and a max of $15.66 (ROI 90.8%, bullish), and culminates in 2050 with an average of $13.79 and a max of $31.72 (ROI 268.7%, bullish). These figures illustrate upside potential while recognizing that outcomes are estimates, not guarantees, and are subject to market and development risks.
Tap a question to reveal the answer.
2030 avg price is $4.59, with a min of $2.84 and a max of $7.98; ROI is 22.9% and sentiment is BULLISH.
Forecasts show neutral sentiment in 2026–2029 and bullish sentiment from 2030 onward, with ROI of 22.9% in 2030, 90.8% in 2040, and 268.7% in 2050, highlighting upside potential while noting this is an estimate, not a guarantee.
Yes. The max forecast for 2033 is $10.38, with 2031 max $9.93, 2032 max $9.79, and 2030 max $7.98.
Current price is $3.74 and market cap is $34.63M.
Sentiment is BULLISH with RSI(14) at 60. The 50-day SMA is $3.37 and the 200-day SMA is $5.65. Support is at $2.25, resistance at $4.52, and the 30-day range is $2.25 to $6.23.
CervoMed Inc. Community Discussion
0Share your CervoMed Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.